iBio Balance Sheet Health
Financial Health criteria checks 1/6
iBio has a total shareholder equity of $9.2M and total debt of $13.1M, which brings its debt-to-equity ratio to 142.8%. Its total assets and total liabilities are $34.0M and $24.8M respectively.
Key information
142.8%
Debt to equity ratio
US$13.14m
Debt
| Interest coverage ratio | n/a |
| Cash | US$2.79m |
| Equity | US$9.20m |
| Total liabilities | US$24.83m |
| Total assets | US$34.02m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0JV0's short term assets ($19.7M) do not cover its short term liabilities ($21.6M).
Long Term Liabilities: 0JV0's short term assets ($19.7M) exceed its long term liabilities ($3.3M).
Debt to Equity History and Analysis
Debt Level: 0JV0's net debt to equity ratio (112.5%) is considered high.
Reducing Debt: 0JV0's debt to equity ratio has increased from 0% to 142.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0JV0 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 0JV0 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 20.9% each year